Covid-19 virus to become resistant to antibody drugs, GeoVax’s GEO-CM04S1 targets the virus in two places and stimulates immunoresponse
Researchers stated that an experimental vaccine produced by GeoVax Labs Inc promoted the formation of antibodies that target two separate
Read more